Please use this identifier to cite or link to this item:
|Title:||Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives|
Natural product library
|Citation:||McCulloch, M.W.B., Coombs, G.S., Banerjee, N., Bugni, T.S., Cannon, K.M., Harper, M.K., Veltri, C.A., Virshup, D.M., Ireland, C.M. (2009-03-15). Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. Bioorganic and Medicinal Chemistry 17 (6) : 2189-2198. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bmc.2008.10.077|
|Abstract:||The Wnt signaling pathway regulates cell growth and development in metazoans, and is therefore of interest for drug discovery. By screening a library of 5808 pre-fractionated marine extracts in a cell-based Wnt signaling assay, several signaling activators and inhibitors were observed. LCMS-based fractionation rapidly identified an active compound from Pseudoceratina purpurea as psammaplin A, a known HDAC inhibitor. Other HDAC inhibitors similarly activated signaling in this assay, indicating HDAC inhibitors will be identified through many cell-based reporter assays. In a large scale analysis of P. purpurea, three previously undescribed bromotyrosine based natural products were identified; the structure of one of these was confirmed by synthesis. Additionally, three other derivatives of psammaplin A were prepared: a mixed disulfide and two sulfinate esters. Finally, evidence to support a structural reassignment of psammaplin I from a sulfone to the isomeric sulfinate ester is presented. © 2008.|
|Source Title:||Bioorganic and Medicinal Chemistry|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jan 14, 2019
WEB OF SCIENCETM
checked on Jan 7, 2019
checked on Nov 15, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.